8 completed, 1 terminated. 3 Not applicable, 3 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Stage IIIB Cervical Cancer: new trials by email Literature Review of Stage IIIB Cervical Cancer trials Research Report on Stage IIIB Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners Cognitive Behavior Therapy, Quality-of-Life Assessment, Questionnaire Administration - Malignant Female Reproductive System Neoplasm, Malignant Hepatobiliary Neoplasm | Not applicable | Completed | Rutgers, The State University of New Jersey | 14 | 2017-12-06 | 2021-04-08 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations Laboratory Biomarker Analysis, Nanoparticle Albumin-Bound Rapamycin, Quality-of-Life Assessment - Advanced Malignant Neoplasm, Cervical Squamous Cell Carcinoma | Early Phase 1 | Completed | Mayo Clinic | 2 | 2016-01-01 | 2019-06-06 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors Informational Intervention - Stage I Breast Cancer, Stage I Cervical Cancer | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 40 | 2015-08-01 | 2025-04-29 |
| MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer Computed Tomography, Diffusion Weighted Imaging, Dynamic Contrast-Enhanced Magnetic Resonance Imaging - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Terminated | University of Washington | 51 | 2014-02-14 | 2023-06-26 | |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers educational intervention, telephone-based intervention, quality-of-life assessment - Healthy Subject, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter | Not applicable | Completed | City of Hope Medical Center | 200 | 2013-10-29 | 2026-10-01 |
| Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer eribulin mesylate - Recurrent Cervical Cancer, Stage IIIA Cervical Cancer | Phase 2 | Completed | University of Southern California | 32 | 2012-08-09 | 2025-11-06 |
| Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer behavioral, psychological or informational intervention - Ovarian Sarcoma, Ovarian Stromal Cancer | Phase 2 | Completed | Ohio State University Comprehensive Cancer Center | 100 | 2010-10-01 | 2018-05-30 |
| Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery Temsirolimus, Laboratory Biomarker Analysis - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 38 | 2009-12-01 | 2015-09-10 |
| Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies triapine, laboratory biomarker analysis, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 2006-03-01 | 2013-01-11 |
Uterine Cervical Neoplasms (9) · Breast Neoplasms (4) · Carcinoma, Ovarian Epithelial (3) · Carcinoma, Renal Cell (2) · Endometrial Neoplasms (2) · Lung Neoplasms (2) · Ovarian Neoplasms (2) · Prostatic Neoplasms (2) · Urinary Bladder Neoplasms (2) · Vaginal Neoplasms (2) · Vulvar Neoplasms (2) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Fallopian Tube Neoplasms (1) · Gestational Trophoblastic Disease (1)
Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Genital Diseases (9) · Genital Diseases, Female (9) · Genital Neoplasms, Female (9) · Neoplasms by Site (9) · Urogenital Diseases (9) · Urogenital Neoplasms (9) · Uterine Cervical Diseases (9) · Uterine Diseases (9) · Neoplasms (8) · Uterine Neoplasms (8) · Adnexal Diseases (5) · Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5)
3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · Brachytherapy (1) · Cisplatin (1) · Cognitive Behavioral Therapy (1) · Early Intervention, Educational (1) · Fluorodeoxyglucose F18 (1) · Magnetic Resonance Spectroscopy (1) · Methods (1) · Therapeutics (1) · eribulin (1) · temsirolimus (1)
National Cancer Institute (NCI) (2) · City of Hope Medical Center (1) · Mayo Clinic (1) · Ohio State University Comprehensive Cancer Center (1) · Rutgers, The State University of New Jersey (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of Southern California (1) · University of Washington (1)
United States (8) · Canada (2) · Hong Kong (1)
Andrea Barsevick, PhD (1) · Anna Tinker (1) · Betty Ferrell (1) · Charles Kunos (1) · Kristen M. Carpenter, Ph.D (1) · Lynda Roman, MD (1) · Mitesh Borad (1) · Sharon Manne (1) · Simon Lo (1)
P30CA015083 (1), P30CA072720 (1), R01CA155454 (1), R21CA149675 (1), U01CA062502 (1)